The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Intracranial Arteriosclerosis

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Intracranial Arteriosclerosis


High impact information on Intracranial Arteriosclerosis


Chemical compound and disease context of Intracranial Arteriosclerosis


Biological context of Intracranial Arteriosclerosis


Anatomical context of Intracranial Arteriosclerosis


Gene context of Intracranial Arteriosclerosis


  1. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Ellis, R.J., Olichney, J.M., Thal, L.J., Mirra, S.S., Morris, J.C., Beekly, D., Heyman, A. Neurology (1996) [Pubmed]
  2. Thiethylperazine and tardive dyskinesia. Sulkava, R. Acta neurologica Scandinavica. (1984) [Pubmed]
  3. Cerebral ischemia: new risk factors. Diaz, J., Sempere, A.P. Cerebrovasc. Dis. (2004) [Pubmed]
  4. Staining of minerals and solubility of iron in tissues. Klavins, J.V., Pickett, J.P., Wessely, Z. Ann. Clin. Lab. Sci. (1976) [Pubmed]
  5. The reported clinical utility of taurine in ischemic disorders may reflect a down-regulation of neutrophil activation and adhesion. McCarty, M.F. Med. Hypotheses (1999) [Pubmed]
  6. Cerebral atherosclerosis in Japanese. Part 5: relationship between cholesterol deposition and glycosaminoglycans. Nakamura, M., Imaizumi, K., Shigemi, U., Nakashima, Y., Kikuchi, Y. Stroke (1976) [Pubmed]
  7. Aging and cerebral vasodilator responses to hypercarbia: responses in normal aging and in persons with risk factors for stroke. Yamamoto, M., Meyer, J.S., Sakai, F., Yamaguchi, F. Arch. Neurol. (1980) [Pubmed]
  8. Clinical features and management of adverse effects of quinolone antibacterials. Paton, J.H., Reeves, D.S. Drug safety : an international journal of medical toxicology and drug experience. (1991) [Pubmed]
  9. Cerebral and aortic atherosclerosis in Hisayama, Japan. Sadoshima, S., Kurozumi, T., Tanaka, K., Ueda, K., Takeshita, M., Hirota, Y., Omae, T., Uzawa, H., Katsuki, S. Atherosclerosis (1980) [Pubmed]
  10. The relationship between endothelin-1, event-related P300 potentials, and prognosis in cerebral arteriosclerosis. Kügler, C.F., Funk, H., Vlajic, P., Platt, D. Journal of the American Geriatrics Society. (1997) [Pubmed]
  11. Cyclandelate in the treatment of cerebral arteriosclerosis. Hall, P. Journal of the American Geriatrics Society. (1976) [Pubmed]
  12. Age-related changes in regional cerebral blood flow and brain volume in healthy subjects. Takeda, S., Matsuzawa, T., Matsui, H. Journal of the American Geriatrics Society. (1988) [Pubmed]
  13. Flunarizine, cerebral blood flow and reversion of experimental atherosclerosis in rabbit. Favalli, L., Lanza, E., Rozza Dionigi, A., Assogna, G., Goggi, D., Ricevuti, G. Drugs under experimental and clinical research. (1985) [Pubmed]
  14. Platelet arachidonic acid metabolism in severe cerebrovascular disease. Sié, P., Perret, B., Cousin, F., Mauco, G., Boneu, B., Chap, H.J., Rascol, A., Douste-Blazy, L. Thromb. Res. (1982) [Pubmed]
  15. Advances in stent-assisted management of intracranial occlusive disease and cerebral aneurysms. Hanel, R.A., Levy, E.I., Guterman, L.R., Hopkins, L.N. Techniques in vascular and interventional radiology. (2004) [Pubmed]
  16. The influence of the degree of cerebral atherosclerosis on the changes in hemostatic system in patients with ischemic brain disease and atherosclerotic encephalopathy. Raicević, R., Jovicić, A., Mandić-Radić, S., Krgović, M., Magdić, B., Marković, L., Hajduković, D., Jovic, P. Vojnosanitetski pregled. Military-medical and pharmaceutical review. (1999) [Pubmed]
  17. Effect of cardiac glycosides on the release of adenylate kinase into cerebrospinal fluid of patients with cerebral arteriosclerosis. Ronquist, G., Frithz, G. Eur. Neurol. (1982) [Pubmed]
  18. Hyperreactive arterial endothelial cells in atherogenesis and cyclic AMP phosphodiesterase inhibitor in prevention and treatment of atherosclerotic disorders. Shimamoto, T. Japanese heart journal. (1975) [Pubmed]
  19. Basal ganglia infarction demonstrated by radionuclide brain imaging. Kim, E.E., Schacht, R.A., Domstad, P.A., DeLand, F.H. Clinical nuclear medicine. (1982) [Pubmed]
  20. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Kosunen, O., Talasniemi, S., Lehtovirta, M., Heinonen, O., Helisalmi, S., Mannermaa, A., Paljärvi, L., Ryynänen, M., Riekkinen, P.J., Soininen, H. Stroke (1995) [Pubmed]
  21. Angiogenesis in symptomatic intracranial atherosclerosis: predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence. Arenillas, J.F., Alvarez-Sabín, J., Montaner, J., Rosell, A., Molina, C.A., Rovira, A., Ribó, M., Sánchez, E., Quintana, M. Stroke (2005) [Pubmed]
  22. Cerebral atherosclerosis in Japanese. Part 4: relationship between lipid content and macroscopic severity of atherosclerosis. Nakamura, M., Imaizumi, K., Kikuchi, Y., Kanaide, H. Stroke (1976) [Pubmed]
  23. Immunohistochemical detection of intracranial vasa vasorum: a human autopsy study. Connolly, E.S., Huang, J., Goldman, J.E., Holtzman, R.N. Neurosurgery (1996) [Pubmed]
  24. Medical treatment of peripheral artery occlusive disease (PAOD). Clement, D.L. Acta chirurgica Belgica. (2000) [Pubmed]
WikiGenes - Universities